Terms: = Gastric cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
17 results:
1. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
[TBL] [Abstract] [Full Text] [Related]
2. TETology: Epigenetic Mastermind in Action.
Seethy A; Pethusamy K; Chattopadhyay I; Sah R; Chopra A; Dhar R; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1701-1726. PubMed ID: 33694104
[TBL] [Abstract] [Full Text] [Related]
3. Matrix stiffness epigenetically regulates the oncogenic activation of the Yes-associated protein in gastric cancer.
Jang M; An J; Oh SW; Lim JY; Kim J; Choi JK; Cheong JH; Kim P
Nat Biomed Eng; 2021 Jan; 5(1):114-123. PubMed ID: 33288878
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
5. FGFR3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
6. Demethylation of the RB1 promoter concomitant with reactivation of tet2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
[TBL] [Abstract] [Full Text] [Related]
7. Somatic mutation and loss of expression of a candidate tumor suppressor gene TET3 in gastric and colorectal cancers.
Mo HY; An CH; Choi EJ; Yoo NJ; Lee SH
Pathol Res Pract; 2020 Mar; 216(3):152759. PubMed ID: 31859118
[TBL] [Abstract] [Full Text] [Related]
8. Potential role of tet2 in gastric cancer cisplatin resistance.
Zhou K; Guo H; Zhang J; Zhao D; Zhou Y; Zheng Z; Xu Y; Li Y; Wang D
Pathol Res Pract; 2019 Nov; 215(11):152637. PubMed ID: 31570278
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling.
Deng W; Zhang Y; Cai J; Zhang J; Liu X; Yin J; Bai Z; Yao H; Zhang Z
Exp Biol Med (Maywood); 2019 Sep; 244(12):953-959. PubMed ID: 31242038
[TBL] [Abstract] [Full Text] [Related]
10. tet2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract] [Full Text] [Related]
12. tet2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells.
Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
IUBMB Life; 2016 May; 68(5):355-64. PubMed ID: 27027260
[TBL] [Abstract] [Full Text] [Related]
13. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract] [Full Text] [Related]
14. Loss of function of tet2 cooperates with constitutively active KIT in murine and human models of mastocytosis.
De Vita S; Schneider RK; Garcia M; Wood J; Gavillet M; Ebert BL; Gerbaulet A; Roers A; Levine RL; Mullally A; Williams DA
PLoS One; 2014; 9(5):e96209. PubMed ID: 24788138
[TBL] [Abstract] [Full Text] [Related]
15. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P
J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508
[TBL] [Abstract] [Full Text] [Related]
16. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
17. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Kudo Y; Tateishi K; Yamamoto K; Yamamoto S; Asaoka Y; Ijichi H; Nagae G; Yoshida H; Aburatani H; Koike K
Cancer Sci; 2012 Apr; 103(4):670-6. PubMed ID: 22320381
[TBL] [Abstract] [Full Text] [Related]